Ki: 1.7 nM (A2AR)
[1]. Alexandra Borodovsky, et al. Abstract 5580: Preclinical pharmacodynamics and antitumor activity of AZD4635, a novel adenosine 2A receptor inhibitor that reverses adenosine mediated T cell suppression. AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 5580.
陕西缔都医药有限责任公司
联系商家时请提及chemicalbook,有助于交易顺利完成!